Health and Medical Research and Innovation Must Be Central to Australia’s Productivity Reform Agenda

Research Australia, the national peak body for health and medical research and innovation is calling on the Federal Government to formally recognise health and medical research, development and innovation as a cornerstone of Australia’s productivity and economic growth strategy.

In its submission to the Treasury’s Economic Reform Roundtable, Research Australia has highlighted the sector as a nationally significant driver of productivity, economic
diversification and resilience.

“Investing in health and medical research and innovation is not just good for our health – it is smart economic policy,” said Nadia Levin, CEO of Research Australia. “Every dollar invested delivers at least four dollars in return to the Australian economy.”

Health and medical research and innovation improves healthcare efficiency, drives high value industries, reduces the burden of disease, and supports a skilled and innovative workforce. With smarter investment and strong policy coordination, the sector can deliver even greater returns for the economy and the Australian people.

“We are urging the Government to elevate HMR as a key productivity lever,” Ms Levin said. “A strong and sustainable health innovation system will help solve some of our biggest challenges, from rising costs of care to workforce pressures and climate-related health risks.”

“All Australians benefit from a strong and forward-looking health research system,” Ms Levin said. “This is our opportunity to make it a driver of lasting economic and societal value.”

Read Research Australia’s full submission here.

Health and Medical Research and Innovation Must Be Central to Australia’s Productivity Reform Agenda

Research Australia, the national peak body for health and medical research and innovation is calling on the Federal Government to formally recognise health and medical research, development and innovation as a cornerstone of Australia’s productivity and economic growth strategy. In its submission to the Treasury’s Economic Reform Roundtable, Research Australia has highlighted the sector as a nationally significant driver of productivity, economic diversification and resilience.

It is well established, every dollar invested in Australian health and medical research yields close to $4 to the Australian economy, however, it is likely to be much more. Beyond immediate health benefits, the sector drives job creation, supports high-value industries, and improves workforce participation by reducing the burden of disease. National prioritisation of health and medical research, development and innovation will position Australia as a leader in global innovation, enhance economic diversification, and respond to demographic and healthcare system pressures with evidence-driven solutions.

Australia’s health and medical research, development and innovation sector is a nationally significant driver of productivity, economic diversification and resilience, growth and budget sustainability. Australia’s health, medical research, development and innovation sector can fulfil its potential as a cornerstone of a more productive, diverse and prosperous Australian economy, but we must have the vision, system-wide policies and enablers, smarter investment, industrial capacity, the manufacturing sector, and the workforce skills to make this happen.

Read our full submission here.

Research Australia creates forum to develop Australia’s digital health and health data infrastructure

On 5th June 2025, Research Australia and Digital Health CRC co-hosted a virtual workshop with key stakeholders from across the health and medical data, research and innovation ecosystem, including government, academia, and industry.

The workshop explored how a unified national coordinated data capabilities could strengthen data-driven healthcare, accelerate research and innovation, and improve health outcomes and economic performance. It focused on how such coordination could be structured, where it might be best situated, and how it could align with current reforms, particularly the National Health and Medical Research Strategy (National Strategy), the Strategic Examination of R&D (SERD), and the National Research Infrastructure Roadmap (NRIR).

The event brought together 25 representatives from 18 organisations, including government representatives from the National Strategy, SERD, and NRIR secretariats and policy directors.

The full communique from the workshop can be found here.